A novel proteochemometrics model for predicting the inhibition of nine carbonic anhydrase isoforms based on supervised Laplacian score and k-nearest neighbour regression

References

• C.T. Supuran, Carbonic anhydrase inhibition/activation: Trip of a scientist around the world in the search of novel chemotypes and drug targets, Curr. Pharm. Des. 16 (2010), pp. 3233–3245.
   PubMed Web of Science ®Google Scholar
• F. Erdemir, D.B. Celepci, A. Aktaş, P. Taslimi, Y. Gök, H. Karabıyık, and İ. Gülçin, 2-Hydroxyethyl substituted NHC precursors: Synthesis, characterization, crystal structure and carbonic anhydrase, α-glycosidase, butyrylcholinesterase, and acetylcholinesterase inhibitory properties, J. Mol. Struct. 1155 (2018), pp. 797–806.
   Web of Science ®Google Scholar
• Y. Sarı, A. Aktaş, P. Taslimi, Y. Gök, and İ. Gulçin, Novel N‐propylphthalimide‐and 4‐vinylbenzyl‐substituted benzimidazole salts: Synthesis, characterization, and determination of their metal chelating effects and inhibition profiles against acetylcholinesterase and carbonic anhydrase enzymes, J. Biochem. Mol. Toxicol. 32 (2018), pp. e22009. Available at http://onlinelibrary.wiley.com/doi/10.1002/jbt.22009/full.
   PubMed Web of Science ®Google Scholar
• C.T. Supuran, Carbonic anhydrase inhibitors and activators for novel therapeutic applications, Future Med. Chem. 3 (2011), pp. 1165–1180.
   PubMed Web of Science ®Google Scholar
• R. Perfetto, S. Del Prete, D. Vullo, G. Sansone, C. Barone, M. Rossi, C.T. Supuran, and C. Capasso, Sequence analysis, kinetic constants, and anion inhibition profile of the nacrein-like protein (CgiNAP2X1) from the Pacific oyster Magallana gigas (Ex-Crassostrea gigas), Mar. Drugs 15 (2017), pp. 270–284.
   PubMed Web of Science ®Google Scholar
• S. Yılmaz, Y. Akbaba, B. Özgeriş, L.P. Köse, S. Göksu, İ. Gülçin, S.H. Alwasel, and C.T. Supuran, Synthesis and inhibitory properties of some carbamates on carbonic anhydrase and acetylcholine esterase, J. Enzyme Inhib. Med. Chem. 31 (2016), pp. 1484–1491.
   PubMed Web of Science ®Google Scholar
• M. Bozdag, M. Pinard, F. Carta, E. Masini, A. Scozzafava, R. McKenna, and C.T. Supuran, A class of 4-sulfamoylphenyl-ω-aminoalkyl ethers with effective carbonic anhydrase inhibitory action and antiglaucoma effects, J. Med. Chem. 57 (2014), pp. 9673–9686.
   PubMed Web of Science ®Google Scholar
• N. Lounnas, C. Rosilio, M. Nebout, D. Mary, E. Griessinger, Z. Neffati, J. Chiche, H. Spits, T.J. Hagenbeek, and V. Asnafi, Pharmacological inhibition of carbonic anhydrase XII interferes with cell proliferation and induces cell apoptosis in T-cell lymphomas, Cancer Lett. 333 (2013), pp. 76–88.
   PubMed Web of Science ®Google Scholar
• M. Ceruso, S. Antel, A. Scozzafava, and C.T. Supuran, Synthesis and inhibition potency of novel ureido benzenesulfonamides incorporating GABA as tumor-associated carbonic anhydrase IX and XII inhibitors, J. Enzyme Inhib. Med. Chem. 31 (2016), pp. 205–211.
   PubMed Web of Science ®Google Scholar
• Y. Budak, U.M. Kocyigit, M.B. Gürdere, K. Özcan, P. Taslimi, İ. Gülçin, and M. Ceylan, Synthesis and investigation of antibacterial activities and carbonic anhydrase and acetyl cholinesterase inhibition profiles of novel 4, 5-dihydropyrazol and pyrazolyl-thiazole derivatives containing methanoisoindol-1, 3-dion unit, Synth. Commun. 47 (2017), pp. 2313–2323.
   Web of Science ®Google Scholar
• U.M. Kocyigit, Y. Budak, F. Eligüzel, P. Taslimi, D. Kılıç, İ. Gulçin, and M. Ceylan, Synthesis and carbonic anhydrase inhibition of tetrabromo chalcone derivatives, Arch. Pharm. (Weinheim) 350 (2017), PP. 1700198. Available at http://onlinelibrary.wiley.com/doi/10.1002/ardp.201700198/abstract.
   PubMed Web of Science ®Google Scholar
• E. Nazarshodeh and S. Gharaghani, Toward a hierarchical virtual screening and toxicity risk analysis for identifying novel CA XII inhibitors, Biosystems 162 (2017), pp. 35–43.
   PubMed Web of Science ®Google Scholar
• R. Sheikhpour, M.A. Sarram, M. Rezaeian, and E. Sheikhpour, QSAR modelling using combined simple competitive learning networks and RBF neural networks, SAR QSAR Environ. Res. 29 (2018), pp. 257–276.
   PubMed Web of Science ®Google Scholar
• E. Nazarshodeh, F. Shiri, and J.B. Ghasemi, 3D-QSAR and virtual screening studies in identification of new Rho kinase inhibitors with different scaffolds, J. Iran. Chem. Soc. 12 (2015), pp. 1945–1959.
   Web of Science ®Google Scholar
• J.B. Ghasemi, E. Nazarshodeh, and H. Abedi, Molecular docking, 2D and 3D-QSAR studies of new indole-based derivatives as HCV-NS5B polymerase inhibitors, J. Iran. Chem. Soc. 12 (2015), pp. 1789–1799.
   Web of Science ®Google Scholar
• R. Sheikhpour, M.A. Sarram, S. Gharaghani, and M.A.Z. Chahooki, Feature selection based on graph Laplacian by using compounds with known and unknown activities, J. Chemom. 31 (2017), pp. e2899. Available at http://onlinelibrary.wiley.com/doi/10.1002/cem.2899/abstract.
   PubMed Web of Science ®Google Scholar
• G.J.P. van Westen, J.K. Wegner, A.P. IJzerman, H.W.T. van Vlijmen, and A. Bender, Proteochemometric modeling as a tool to design selective compounds and for extrapolating to novel targets, Medchemcomm 2 (2011), pp. 16–30.
   Web of Science ®Google Scholar
• I. Cortés-Ciriano, Q.U. Ain, V. Subramanian, E.B. Lenselink, O. Méndez-Lucio, A.P. IJzerman, G. Wohlfahrt, P. Prusis, T.E. Malliavin, and G.J.P. van Westen, Polypharmacology modelling using proteochemometrics (PCM): Recent methodological developments, applications to target families, and future prospects, Medchemcomm 6 (2015), pp. 24–50.
   Web of Science ®Google Scholar
• A. Kontijevskis, J.E.S. Wikberg, and J. Komorowski, Computational proteomics analysis of HIV-1 protease interactome, Proteins Struct. Funct. Bioinforma. 68 (2007), pp. 305–312.
   PubMed Web of Science ®Google Scholar
• H. Strömbergsson, A. Kryshtafovych, P. Prusis, K. Fidelis, J.E.S. Wikberg, J. Komorowski, and T.R. Hvidsten, Generalized modeling of enzyme–ligand interactions using proteochemometrics and local protein substructures, Proteins Struct. Funct. Bioinforma. 65 (2006), pp. 568–579.
   PubMed Web of Science ®Google Scholar
• H. Strömbergsson, P. Prusis, H. Midelfart, M. Lapinsh, J.E.S. Wikberg, and J. Komorowski, Rough set-based proteochemometrics modeling of G-protein-coupled receptor-ligand interactions, Proteins Struct. Funct. Bioinforma. 63 (2006), pp. 24–34.
   PubMed Web of Science ®Google Scholar
• B. Rasti, M.H. Karimi-Jafari, and J.B. Ghasemi, Quantitative characterization of the interaction space of the mammalian carbonic anhydrase isoforms I, II, VII, IX, XII, and XIV and their Inhibitors, using the proteochemometric approach, Chem. Biol. Drug Des. 88 (2016), pp. 341–353.
   PubMed Web of Science ®Google Scholar
• B. Rasti, M. Namazi, M.H. Karimi‐Jafari, and J.B. Ghasemi, Proteochemometric modeling of the interaction space of carbonic anhydrase and its inhibitors: An assessment of structure‐based and sequence‐based descriptors, Mol. Inform. 36 (2016), pp. 1600102. Available at http://onlinelibrary.wiley.com/doi/10.1002/minf.201600102/abstract.
   PubMed Web of Science ®Google Scholar
• C.W. Yap, PaDEL-descriptor: An open source software to calculate molecular descriptors and fingerprints, J. Comput. Chem. 32 (2011), pp. 1466–1474.
   PubMed Web of Science ®Google Scholar
• M. Bozdag, A.M. Alafeefy, D. Vullo, F. Carta, N. Dedeoglu, A.-M.S. Al-Tamimi, N.A. Al-Jaber, A. Scozzafava, and C.T. Supuran, Benzenesulfonamides incorporating bulky aromatic/heterocyclic tails with potent carbonic anhydrase inhibitory activity, Bioorg. Med. Chem. 23 (2015), pp. 7751–7764.
   PubMed Web of Science ®Google Scholar
• S. Carradori, D. Secci, C. De Monte, A. Mollica, M. Ceruso, A. Akdemir, A.P. Sobolev, R. Codispoti, F. De Cosmi, and P. Guglielmi, A novel library of saccharin and acesulfame derivatives as potent and selective inhibitors of carbonic anhydrase IX and XII isoforms, Bioorg. Med. Chem. 24 (2016), pp. 1095–1105.
   PubMed Web of Science ®Google Scholar
• M. Durgun, H. Turkmen, M. Ceruso, and C.T. Supuran, Synthesis of 4-sulfamoylphenyl-benzylamine derivatives with inhibitory activity against human carbonic anhydrase isoforms I, II, IX and XII, Bioorg. Med. Chem. 24 (2016), pp. 982–988.
   PubMed Web of Science ®Google Scholar
• W.M. Eldehna, M. Fares, M. Ceruso, H.A. Ghabbour, S.M. Abou-Seri, H.A. Abdel-Aziz, D.A.A. El Ella, and C.T. Supuran, Amido/ureidosubstituted benzenesulfonamides-isatin conjugates as low nanomolar/subnanomolar inhibitors of the tumor-associated carbonic anhydrase isoform XII, Eur. J. Med. Chem. 110 (2016), pp. 259–266.
   PubMed Web of Science ®Google Scholar
• C.L. Lomelino, B.P. Mahon, R. McKenna, F. Carta, and C.T. Supuran, Kinetic and X-ray crystallographic investigations on carbonic anhydrase isoforms I, II, IX and XII of a thioureido analog of SLC-0111, Bioorg. Med. Chem. 24 (2016), pp. 976–981.
   PubMed Web of Science ®Google Scholar
• A. Nocentini, M. Ceruso, F. Carta, and C.T. Supuran, 7-Aryl-triazolyl-substituted sulfocoumarins are potent, selective inhibitors of the tumor-associated carbonic anhydrase IX and XII, J. Enzyme Inhib. Med. Chem. 31 (2015), pp. 1–8.
   PubMed Web of Science ®Google Scholar
• A. Petrou, A. Geronikaki, E. Terzi, O.O. Guler, T. Tuccinardi, and C.T. Supuran, Inhibition of carbonic anhydrase isoforms I, II, IX and XII with secondary sulfonamides incorporating benzothiazole scaffolds, J. Enzyme Inhib. Med. Chem. 31 (2016), pp. 1–6.
   Web of Science ®Google Scholar
• A.M. Alafeefy, F. Carta, M. Ceruso, A.-M.S. Al-Tamimi, A.A. Al-Kahtani, and C.T. Supuran, Development of 3-(4-aminosulphonyl)-phenyl-2-mercapto-3H-quinazolin-4-ones as inhibitors of carbonic anhydrase isoforms involved in tumorigenesis and glaucoma, Bioorg. Med. Chem. 24 (2016), pp. 1402–1407.
   PubMed Web of Science ®Google Scholar
• E. Barresi, S. Salerno, A.M. Marini, S. Taliani, C. La Motta, F. Simorini, F. Da Settimo, D. Vullo, and C.T. Supuran, Sulfonamides incorporating heteropolycyclic scaffolds show potent inhibitory action against carbonic anhydrase isoforms I, II, IX and XII, Bioorg. Med. Chem. 24 (2016), pp. 921–927.
   PubMed Web of Science ®Google Scholar
• P. Khloya, M. Ceruso, S. Ram, C.T. Supuran, and P.K. Sharma, Sulfonamide bearing pyrazolylpyrazolines as potent inhibitors of carbonic anhydrase isoforms I, II, IX and XII, Bioorg. Med. Chem. Lett. 25 (2015), pp. 3208–3212.
   PubMed Web of Science ®Google Scholar
• R. Meleddu, E. Maccioni, S. Distinto, G. Bianco, C. Melis, S. Alcaro, F. Cottiglia, M. Ceruso, and C.T. Supuran, New 4-[(3-cyclohexyl-4-aryl-2, 3-dihydro-1, 3-thiazol-2-ylidene) amino] benzene-1-sulfonamides, synthesis and inhibitory activity toward carbonic anhydrase I, II, IX, XII, Bioorg. Med. Chem. Lett. 25 (2015), pp. 3281–3284.
   PubMed Web of Science ®Google Scholar
• F.M. Awadallah, T.A. El-Waei, M.M. Hanna, S.E. Abbas, M. Ceruso, B.E. Oz, O.O. Guler, and C.T. Supuran, Synthesis, carbonic anhydrase inhibition and cytotoxic activity of novel chromone-based sulfonamide derivatives, Eur. J. Med. Chem. 96 (2015), pp. 425–435.
   PubMed Web of Science ®Google Scholar
• C. Congiu, V. Onnis, A. Deplano, G. Balboni, N. Dedeoglu, and C.T. Supuran, Synthesis of sulfonamides incorporating piperazinyl-ureido moieties and their carbonic anhydrase I, II, IX and XII inhibitory activity, Bioorg. Med. Chem. Lett. 25 (2015), pp. 3850–3853.
   PubMed Web of Science ®Google Scholar
• D.A. Ibrahim, D.S. Lasheen, M.Y. Zaky, A.W. Ibrahim, D. Vullo, M. Ceruso, C.T. Supuran, and D.A.A. El Ella, Design and synthesis of benzothiazole-6-sulfonamides acting as highly potent inhibitors of carbonic anhydrase isoforms I, II, IX and XII, Bioorg. Med. Chem. 23 (2015), pp. 4989–4999.
   PubMed Web of Science ®Google Scholar
• M. Durgun, H. Turkmen, M. Ceruso, and C.T. Supuran, Synthesis of Schiff base derivatives of 4-(2-aminoethyl)-benzenesulfonamide with inhibitory activity against carbonic anhydrase isoforms I, II, IX and XII, Bioorg. Med. Chem. Lett. 25 (2015), pp. 2377–2381.
   PubMed Web of Science ®Google Scholar
• B. Żołnowska, J. Sławiński, A. Pogorzelska, J. Chojnacki, D. Vullo, and C.T. Supuran, Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N′-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl) guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII, Eur. J. Med. Chem. 71 (2014), pp. 135–147.
   PubMed Web of Science ®Google Scholar
• Ö. Güzel-Akdemir, A. Akdemir, N. Karalı, and C.T. Supuran, Discovery of novel isatin-based sulfonamides with potent and selective inhibition of the tumor-associated carbonic anhydrase isoforms IX and XII, Org. Biomol. Chem. 13 (2015), pp. 6493–6499.
   PubMed Web of Science ®Google Scholar
• A. Nocentini, F. Carta, M. Ceruso, G. Bartolucci, and C.T. Supuran, Click-tailed coumarins with potent and selective inhibitory action against the tumor-associated carbonic anhydrases IX and XII, Bioorg. Med. Chem. 23 (2015), pp. 6955–6966.
   PubMed Web of Science ®Google Scholar
• İ. Esirden, R. Ulus, B. Aday, M. Tanç, C.T. Supuran, and M. Kaya, Synthesis of novel acridine bis-sulfonamides with effective inhibitory activity against the carbonic anhydrase isoforms I, II, IX and XII, Bioorg. Med. Chem. 23 (2015), pp. 6573–6580.
   PubMed Web of Science ®Google Scholar
• H.S. Ibrahim, S.M. Abou-Seri, M. Tanc, M.M. Elaasser, H.A. Abdel-Aziz, and C.T. Supuran, Isatin-pyrazole benzenesulfonamide hybrids potently inhibit tumor-associated carbonic anhydrase isoforms IX and XII, Eur. J. Med. Chem. 103 (2015), pp. 583–593.
   PubMed Web of Science ®Google Scholar
• M. Mojzych, M. Ceruso, A. Bielawska, K. Bielawski, E. Fornal, and C.T. Supuran, New pyrazolo [4, 3-e][1, 2, 4] triazine sulfonamides as carbonic anhydrase inhibitors, Bioorg. Med. Chem. 23 (2015), pp. 3674–3680.
   PubMed Web of Science ®Google Scholar
• A. Grandane, M. Tanc, R. Žalubovskis, and C.T. Supuran, Synthesis of 6-aryl-substituted sulfocoumarins and investigation of their carbonic anhydrase inhibitory action, Bioorg. Med. Chem. 23 (2015), pp. 1430–1436.
   PubMed Web of Science ®Google Scholar
• S. Carradori, A. Mollica, M. Ceruso, M. D’Ascenzio, C. De Monte, P. Chimenti, R. Sabia, A. Akdemir, and C.T. Supuran, New amide derivatives of Probenecid as selective inhibitors of carbonic anhydrase IX and XII: Biological evaluation and molecular modelling studies, Bioorg. Med. Chem. 23 (2015), pp. 2975–2981.
   PubMed Web of Science ®Google Scholar
• A. Grandane, M. Tanc, L. Di Cesare Mannelli, F. Carta, C. Ghelardini, R. Žalubovskis, and C.T. Supuran, 6-Substituted sulfocoumarins are selective carbonic anhdydrase IX and XII inhibitors with significant cytotoxicity against colorectal cancer cells, J. Med. Chem. 58 (2015), pp. 3975–3983.
   PubMed Web of Science ®Google Scholar
• I.N. Cvijetić, M. Tanç, I.O. Juranić, T.Ž. Verbić, C.T. Supuran, and B.J. Drakulić, 5-Aryl-1H-pyrazole-3-carboxylic acids as selective inhibitors of human carbonic anhydrases IX and XII, Bioorg. Med. Chem. 23 (2015), pp. 4649–4659.
   PubMed Web of Science ®Google Scholar
• R. Yaseen, D. Ekinci, M. Senturk, A.D. Hameed, S. Ovais, P. Rathore, M. Samim, K. Javed, and C.T. Supura, Pyridazinone substituted benzenesulfonamides as potent carbonic anhydrase inhibitors, Bioorg. Med. Chem. Lett. 26 (2016), pp. 1337–1341.
   PubMed Web of Science ®Google Scholar
• F.Z. Küçükbay, H. Küçükbay, M. Tanc, and C.T. Supuran, Synthesis and carbonic anhydrase inhibitory properties of amino acid–coumarin/quinolinone conjugates incorporating glycine, alanine and phenylalanine moieties, J. Enzyme Inhib. Med. Chem. 31 (2016), pp. 1198–1202.
   PubMed Web of Science ®Google Scholar
• E. Čapkauskaitė, A. Zubrienė, A. Smirnov, J. Torresan, M. Kišonaitė, J. Kazokaitė, J. Gylytė, V. Michailovienė, V. Jogaitė, and E. Manakova, Benzenesulfonamides with pyrimidine moiety as inhibitors of human carbonic anhydrases I, II, VI, VII, XII, and XIII, Bioorg. Med. Chem. 21 (2013), pp. 6937–6947.
   PubMed Web of Science ®Google Scholar
• M.R. Buemi, L. De Luca, S. Ferro, E. Bruno, M. Ceruso, C.T. Supuran, K. Pospíšilová, J. Brynda, P. Řezáčová, and R. Gitto, Carbonic anhydrase inhibitors: Design, synthesis and structural characterization of new heteroaryl-N-carbonylbenzenesulfonamides targeting druggable human carbonic anhydrase isoforms, Eur. J. Med. Chem. 102 (2015), pp. 223–232.
   PubMed Web of Science ®Google Scholar
• A.S. El-Azab, A.-M. Alaa, R.R. Ayyad, M. Ceruso, and C.T. Supuran, Inhibition of carbonic anhydrase isoforms I, II, IV, VII and XII with carboxylates and sulfonamides incorporating phthalimide/phthalic anhydride scaffolds, Bioorg. Med. Chem. 24 (2016), pp. 20–25.
   PubMed Web of Science ®Google Scholar
• A. Sujayev, L. Polat Kose, E. Garibov, İ. Gülçin, V. Farzaliev, S.H. Alwasel, and C.T. Supuran, Synthesis of N-alkyl (aril)-tetra pyrimidine thiones and investigation of their human carbonic anhydrase I and II inhibitory effects, J. Enzyme Inhib. Med. Chem. (2015), pp. 1–6.
   Web of Science ®Google Scholar
• I. Fidan, R.E. Salmas, M. Arslan, M. Şentürk, S. Durdagi, D. Ekinci, E. Şentürk, S. Coşgun, and C.T. Supuran, Carbonic anhydrase inhibitors: Design, synthesis, kinetic, docking and molecular dynamics analysis of novel glycine and phenylalanine sulfonamide derivatives, Bioorg. Med. Chem. 23 (2015), pp. 7353–7358.
   PubMed Web of Science ®Google Scholar
• B. Turan, K. Şendil, E. Şengül, M.S. Gültekin, P. Taslimi, İ. Gulçin, and C.T. Supuran, The synthesis of some β-lactams and investigation of their metal-chelating activity, carbonic anhydrase and acetylcholinesterase inhibition profiles, J. Enzyme Inhib. Med. Chem. 31 (2016), pp. 1–10.
   Web of Science ®Google Scholar
• B. Özgeriş, S. Göksu, L.P. Köse, İ. Gülçin, R.E. Salmas, S. Durdagi, F. Tümer, and C.T. Supuran, Acetylcholinesterase and carbonic anhydrase inhibitory properties of novel urea and sulfamide derivatives incorporating dopaminergic 2-aminotetralin scaffolds, Bioorg. Med. Chem. 24 (2016), pp. 2318–2329.
   PubMed Web of Science ®Google Scholar
• T. Artunç, Y. Çetinkaya, H. Göçer, İ. Gülçin, A. Menzek, E. Şahin, and C.T. Supuran, Synthesis of 4‐[2‐(3, 4‐dimethoxybenzyl) cyclopentyl]‐1, 2‐dimethoxybenzene derivatives and evaluations of their carbonic anhydrase isoenzymes inhibitory effects, Chem. Biol. Drug Des. 87 (2015), pp. 594–607.
   PubMed Web of Science ®Google Scholar
• L.P. Kose, İ. Gulcin, A. Yıldırım, U. Atmaca, M. Çelik, S.H. Alwasel, and C.T. Supuran, The human carbonic anhydrase isoenzymes I and II inhibitory effects of some hydroperoxides, alcohols, and acetates, J. Enzyme Inhib. Med. Chem. 31 (2015), pp. 1–6.
   PubMed Web of Science ®Google Scholar
• H.I. Gul, M. Tugrak, H. Sakagami, P. Taslimi, I. Gulcin, and C.T. Supuran, Synthesis and bioactivity studies on new 4-(3-(4-Substitutedphenyl)-3a, 4-dihydro-3 H-indeno [1, 2-c] pyrazol-2-yl) benzenesulfonamides, J. Enzyme Inhib. Med. Chem. 31 (2016), pp. 1619–1624.
   PubMed Web of Science ®Google Scholar
• H. Release 2002. 7.5 for windows, molecular modeling system. Hypercube Inc; software available at http://www.hyper.com.
   Google Scholar
• A. Zubrienė, J. Smirnovienė, A. Smirnov, V. Morkūnaitė, V. Michailovienė, J. Jachno, V. Juozapaitienė, P. Norvaišas, E. Manakova, and S. Gražulis, Intrinsic thermodynamics of 4-substituted-2, 3, 5, 6-tetrafluorobenzenesulfonamide binding to carbonic anhydrases by isothermal titration calorimetry, Biophys. Chem. 205 (2015), pp. 51–65.
   PubMed Web of Science ®Google Scholar
• L.A. Woods, O. Dolezal, B. Ren, J.H. Ryan, T.S. Peat, and S.-A. Poulsen, Native State Mass Spectrometry, Surface Plasmon Resonance, and X-ray Crystallography Correlate Strongly as a Fragment Screening Combination, J. Med. Chem. 59 (2016), pp. 2192–2204.
   PubMed Web of Science ®Google Scholar
• W. Vernier, W. Chong, D. Rewolinski, S. Greasley, T. Pauly, M. Shaw, D. Dinh, R.A. Ferre, S. Nukui, and M. Ornelas, Thioether benzenesulfonamide inhibitors of carbonic anhydrases II and IV: Structure-based drug design, synthesis, and biological evaluation, Bioorg. Med. Chem. 18 (2010), pp. 3307–3319.
   PubMed Web of Science ®Google Scholar
• E.S. Pilka, G. Kochan, U. Oppermann, and W.W. Yue, Crystal structure of the secretory isozyme of mammalian carbonic anhydrases CA VI: Implications for biological assembly and inhibitor development, Biochem. Biophys. Res. Commun. 419 (2012), pp. 485–489.
   PubMed Web of Science ®Google Scholar
• E. Ugochukwu, N. Shafqat, E. Pilka, A. Chaikuad, T. Krojer, J. Muniz J. Kim, J. Bray, C. Bountra, C.H. Arrowsmith, J. Weigelt, A. Edwards, F. von Delft, E.P. Carpenter, W.W. Yue, and U. Oppermann. Crystal Structure of Human Carbonic Anhydrase VII [isoform 1], CA7. Available at https://www.rcsb.org/structure/3mdz.
   Google Scholar
• J. Leitans, A. Kazaks, A. Balode, J. Ivanova, R. Zalubovskis, C.T. Supuran, and K. Tars, Efficient expression and crystallization system of cancer-associated carbonic anhydrase isoform IX, J. Med. Chem. 58 (2015), pp. 9004–9009.
   PubMed Web of Science ®Google Scholar
• V. Dudutienė, A. Zubrienė, A. Smirnov, D.D. Timm, J. Smirnovienė, J. Kazokaitė, V. Michailovienė, A. Zakšauskas, E. Manakova, and S. Gražulis, Functionalization of fluorinated benzenesulfonamides and their inhibitory properties toward carbonic anhydrases, ChemMedChem 10 (2015), pp. 662–687.
   PubMed Web of Science ®Google Scholar
• G. La Regina, A. Coluccia, V. Famiglini, S. Pelliccia, L. Monti, D. Vullo, E. Nuti, V. Alterio, G. De Simone, and S.M. Mont, Discovery of 1, 1′-biphenyl-4-sulfonamides as a new class of potent and selective carbonic anhydrase xiv inhibitors, J. Med. Chem. 58 (2015), pp. 8564–8572.
   PubMed Web of Science ®Google Scholar
• H.B. Rao, F. Zhu, G.B. Yang, Z.R. Li, and Y.Z. Chen, Update of PROFEAT: A web server for computing structural and physicochemical features of proteins and peptides from amino acid sequence, Nucleic Acids Res. 39 (2011), pp. W385–W390.
   PubMed Web of Science ®Google Scholar
• R. Sheikhpour, M.A. Sarram, and S. Gharaghani, Constraint score for semi-supervised feature selection in ligand-and receptor-based QSAR on serine/threonine-protein kinase PLK3 inhibitors, Chemom. Intell. Lab. Syst. 163 (2017), pp. 31–40.
   Web of Science ®Google Scholar
• H. Moghadam, M. Rahgozar, and S. Gharaghani, Scoring multiple features to predict drug disease associations using information fusion and aggregation, SAR QSAR Environ. Res. 27 (2016), pp. 609–628.
   PubMed Web of Science ®Google Scholar
• X. He, D. Cai, and P. Niyogi, Laplacian Score for Feature Selection, Adv. Neural Inf. Process. Syst. 18 (2005), pp. 507–514.
   Google Scholar
• G. Doquire and M. Verleysen, Graph Laplacian for semi-supervised feature selection in regression problems, International Work-Conference on Artificial Neural Networks (2011), pp. 248–255.
   Google Scholar
• G. Doquire and M. Verleysen, A graph laplacian based approach to semi-supervised feature selection for regression problems, Neurocomputing 121 (2013), pp. 5–13.
   Web of Science ®Google Scholar
• E. Alpaydin, Introduction to Machine Learning, 2nd ed,. MIT Press Cambridge, 2010.
   Google Scholar
• A. Tropsha, P. Gramatica, and V.K. Gombar, The importance of being earnest: Validation is the absolute essential for successful application and interpretation of QSPR models, QSAR Comb. Sci. 22 (2003), pp. 69–77.
   Google Scholar
• A. Golbraikh and A. Tropsha, Beware of q 2!, J. Mol. Graph. Model. 20 (2002), pp. 269–276.
   PubMed Web of Science ®Google Scholar
• P.P. Roy and K. Roy, On some aspects of variable selection for partial least squares regression models, Mol. Inform. 27 (2008), pp. 302–313.
   Google Scholar
• L.H. Hall and L.B. Kier, Electrotopological state indices for atom types: A novel combination of electronic, topological, and valence state information, J. Chem. Inf. Comput. Sci. 35 (1995), pp. 1039–1045.
   Google Scholar
• R. Todeschini and V. Consonni, Molecular Descriptors for Chemoinformatics. Vol. 1. Alphabetical Listing; Vol. 2. Appendices, References, Wiley-VCH, Weinheim, 2009.
   Google Scholar
• A. Nocentini, D. Moi, G. Balboni, V. Onnis, and C.T. Supuran, Discovery of thiazolin-4-one-based aromatic sulfamates as a new class of carbonic anhydrase isoforms I, II, IV, and IX inhibitors, Bioorg. Chem. 77 (2018), pp. 293–299.
   PubMed Web of Science ®Google Scholar
• H.I. Gul, C. Yamali, H. Sakagami, A. Angeli, J. Leitans, A. Kazaks, K. Tars, D.O. Ozgun, and C.T. Supuran, New anticancer drug candidates sulfonamides as selective hCA IX or hCA XII inhibitors, Bioorg. Chem. 77 (2018), pp. 411–419.
   PubMed Web of Science ®Google Scholar